Bombardier Aerospace, Bell Helicopter Textron Canada Limited and Pratt & Whitney Canada have all initiated projects on Additive Manufacturing processes. Although applications are different, all companies are facing the same challenges including the lack of a mature certification path and a mature Canadian supply chain. In order to accelerate the maturation of this technology, we are proposing the first Canadian industryled R&D program on additive manufacturing (AM).
The proposed project is to develop a bioaerosol sampler which will have minimal impact on the infectivity of captured viruses. Airborne viruses are subjected to environmental conditions which could affect their potential of infectivity as well as their capacity to resist the shearing forces and desiccating conditions during sampling procedures with standard sampling apparatuses. This leads to the underestimation of infective viral loads in aerosols and could have a dramatic impact on the nature of the decisions taken for aerosol contamination control.
Prostate cancer is the more common cancer affected men in developed countries. Epidemiological data suggest that omega-3 fatty acids may prevent prostate cancer initiation and progression. However, these data do not decipher which omega-3 fatty acid presents the more potent anticancer properties. SCF Pharma has developed pure and highly bioavailable omega-3 fatty acids monoglycerides. Interestingly, data from SCF Pharma showed that these pure monoglycerides form of fatty acids can reduce the growth and the proliferation rate of prostate cancer cells in culture.
The project covers the design and optimization of long-haul and ultra long-haul wavelength division multiplexing (WDM) networks. The objective is to develop routing and wavelength assignment (RWA) algorithms for next-generation terrestrial and undersea networks that are based on the use of high-speed dual-polarization coherent transponders. The goal is to improve the performance and accuracy of the RWA results and therefore to get more powerful tools for increasing network capacity and planning network migrations.
This project aims at developing new coating materials exhibiting high oxidation, corrosion and wear resistance to addresses the specific needs of power generation equipment, which operate under severe erosion and abrasion conditions in corrosive environments.
Composite structures are vulnerable to impact damage, and have to satisfy certification procedures for high velocity impact from bird strike and foreign object damage. Since performing full scale impact tests is highly expensive and thus impractical, the development of validated analytical tools for the prediction of the structural response is essential for the industry to reduce development costs and to speed up the development process.
SYnRGY is a computational tool designed to support command and control operations in the context of crisis management. Although SYnRGY has been designed from a user-centered perspective, some degree of training is required to bring novice users up to a level of competence required to use the system. The objective of the current proposal is to capture the expert model of crisis management and design a prototype intelligent tutoring system based on that model. The objective will be achieved in three phases. The purpose of the first phase is to develop a realistic crisis management scenario.
A common problem in aircraft cabinetry is deterioration of high gloss finishes, giving an "orange-peel look", which is attributed to some kind of dimensional instability. This can be related to the veneer, the varnish, their interactions and how they evolve over time and in different environmental conditions (temperature and humidity) to which the aircraft cabinetry are exposed during their manufacturing and usage. This problem is costly to Bombardier Aerospace, who must frequently rework the cabinetry surfaces. 3M Canada is interested in providing solutions.
Multiple antibiotic resistances have increased over the past decades, challenging our ability to treat bacterial infections and thwarting our ability to develop new antimicrobial agents. Many resistance genes have not evolved within the pathogenic isolates but were acquired by lateral transfer. We recently showed that genes conferring glycopeptide resistance are highly prevalent in the human flora. Some of these genes are present in novel commensal anaerobic species of the gut suggesting that these bacteria may serve as a reservoir for resistance genes.